{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T01:25:45Z","timestamp":1771982745509,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T00:00:00Z","timestamp":1498089600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s00120-017-0428-y","type":"journal-article","created":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T15:31:03Z","timestamp":1498145463000},"page":"887-894","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Neue (und alte) Aspekte der retroperitonealen Fibrose","New (and old) aspects of retroperitoneal fibrosis"],"prefix":"10.1007","volume":"56","author":[{"given":"A. S.","family":"Brandt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. M.","family":"Dreger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kukuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,22]]},"reference":[{"issue":"9506","key":"428_CR1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(06)68035-5","volume":"367","author":"A Vaglio","year":"2006","unstructured":"Vaglio A, Salvarani C, Buzio C (2006) Retroperitoneal fibrosis. Lancet 367(9506):241\u2013251. doi:\n                        10.1016\/S0140-6736(06)68035-5","journal-title":"Lancet"},{"issue":"6","key":"428_CR2","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1007\/s00120-016-0081-x","volume":"55","author":"AS Brandt","year":"2016","unstructured":"Brandt AS, Kukuk S, Dreger NM, Muller E, Roth S (2016) Diagnosis and treatment of retroperitoneal fibrosis. Urologe\u00a0A 55(6):732\u2013740. doi:\n                        10.1007\/s00120-016-0081-x","journal-title":"Urologe A"},{"issue":"1","key":"428_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/bju.13061","volume":"117","author":"A Fernando","year":"2016","unstructured":"Fernando A, Pattison J, Horsfield C, Bultitude M, D\u2019Cruz D, O\u2019Brien T (2016) A lot of questions (and a\u00a0few answers \u2026) in retroperitoneal fibrosis. BJU Int 117(1):16\u201319. doi:\n                        10.1111\/bju.13061","journal-title":"BJU Int."},{"issue":"2","key":"428_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/1756287214565637","volume":"7","author":"S Cristian","year":"2015","unstructured":"Cristian S, Cristian M, Cristian P, Constantin G, Savu C, Huri E, Sinescu I (2015) Management of idiopathic retroperitoneal fibrosis from the urologist\u2019s perspective. Ther Adv Urol 7(2):85\u201399. doi:\n                        10.1177\/1756287214565637","journal-title":"Ther Adv Urol"},{"issue":"6","key":"428_CR5","doi-asserted-by":"publisher","first-page":"691","DOI":"10.4103\/0366-6999.201606","volume":"130","author":"S Zhang","year":"2017","unstructured":"Zhang S, Chen M, Li CM, Song GD, Liu Y (2017) Differentiation of Lymphoma presenting as Retroperitoneal mass and Retroperitoneal fibrosis: evaluation with multidetector-row computed tomography. Chin Med J (Engl) 130(6):691\u2013697. doi:\n                        10.4103\/0366-6999.201606","journal-title":"Chin Med J (Engl)"},{"issue":"6","key":"428_CR6","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.eururo.2016.10.046","volume":"71","author":"A Fernando","year":"2017","unstructured":"Fernando A, Pattison J, Horsfield C, D\u2019Cruz D, Cook G, O\u2019Brien T (2017) [18F]-Fluorodeoxyglucose positron emission tomography in the diagnosis, treatment stratification, and monitoring of patients with Retroperitoneal fibrosis: a prospective clinical study. Eur Urol 71(6):926\u2013933. doi:\n                        10.1016\/j.eururo.2016.10.046","journal-title":"Eur. Urol."},{"issue":"1","key":"428_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.revmed.2014.10.008","volume":"36","author":"ML Urban","year":"2015","unstructured":"Urban ML, Palmisano A, Nicastro M, Corradi D, Buzio C, Vaglio A (2015) Idiopathic and secondary forms of retroperitoneal fibrosis: a\u00a0diagnostic approach. Rev Med Interne 36(1):15\u201321. doi:\n                        10.1016\/j.revmed.2014.10.008","journal-title":"Rev Med Interne"},{"issue":"12","key":"428_CR8","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00120-015-4011-0","volume":"54","author":"A Kocot","year":"2015","unstructured":"Kocot A, Riedmiller H (2015) Treatment of long-term radiation injuries in the urinary tract. Urologe\u00a0A 54(12):1765\u20131771. doi:\n                        10.1007\/s00120-015-4011-0","journal-title":"Urologe A"},{"key":"428_CR9","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.04.019","author":"RD Swartz","year":"2009","unstructured":"Swartz RD (2009) Idiopathic Retroperitoneal Fibrosis: A Review of the Pathogenesis and Approaches to Treatment. Am J Kidney Dis. doi:\n                        10.1053\/j.ajkd.2009.04.019","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"428_CR10","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.juro.2010.09.105","volume":"185","author":"AS Brandt","year":"2011","unstructured":"Brandt AS, Kamper L, Kukuk S, Haage P, Roth S (2011) Associated findings and complications of retroperitoneal fibrosis in 204 patients: results of a\u00a0urological registry. J\u00a0Urol 185(2):526\u2013531. doi:\n                        10.1016\/j.juro.2010.09.105","journal-title":"J Urol"},{"issue":"8","key":"428_CR11","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/jcp.23.8.681","volume":"23","author":"MJ Mitchinson","year":"1970","unstructured":"Mitchinson MJ (1970) The pathology of idiopathic retroperitoneal fibrosis. J\u00a0Clin Pathol 23(8):681\u2013689","journal-title":"J Clin Pathol"},{"issue":"7","key":"428_CR12","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.autrev.2006.03.011","volume":"5","author":"A Vaglio","year":"2006","unstructured":"Vaglio A, Greco P, Corradi D, Palmisano A, Martorana D, Ronda N, Buzio C (2006) Autoimmune aspects of chronic periaortitis. Autoimmun Rev 5(7):458\u2013464. doi:\n                        10.1016\/j.autrev.2006.03.011","journal-title":"Autoimmun Rev"},{"issue":"1","key":"428_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.autrev.2014.08.006","volume":"14","author":"G Ceresini","year":"2015","unstructured":"Ceresini G, Urban ML, Corradi D, Lauretani F, Marina M, Usberti E, Palmisano A, Buzio C, Vaglio A (2015) Association between idiopathic retroperitoneal fibrosis and autoimmune thyroiditis: a\u00a0case-control study. Autoimmun Rev 14(1):16\u201322. doi:\n                        10.1016\/j.autrev.2014.08.006","journal-title":"Autoimmun Rev"},{"issue":"7","key":"428_CR14","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1093\/rheumatology\/keu462","volume":"54","author":"T Castelein","year":"2015","unstructured":"Castelein T, Coudyzer W, Blockmans D (2015) IgG4-related periaortitis vs idiopathic periaortitis: is there a\u00a0role for atherosclerotic plaque in the pathogenesis of IgG4-related periaortitis? Rheumatology (Oxford) 54(7):1250\u20131256. doi:\n                        10.1093\/rheumatology\/keu462","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"428_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/PAS.0b013e3181342f0d","volume":"32","author":"S Kasashima","year":"2008","unstructured":"Kasashima S, Zen Y, Kawashima A, Konishi K, Sasaki H, Endo M, Matsumoto Y, Kawakami K, Kasashima F, Moriya M, Kimura K, Ohtake H, Nakanuma Y (2008) Inflammatory abdominal aortic aneurysm: close relationship to IgG4-related periaortitis. Am J Surg Pathol 32(2):197\u2013204. doi:\n                        10.1097\/PAS.0b013e3181342f0d","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"428_CR16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/MD.0b013e318289610f","volume":"92","author":"A Khosroshahi","year":"2013","unstructured":"Khosroshahi A, Carruthers MN, Stone JH, Shinagare S, Sainani N, Hasserjian RP, Deshpande V (2013) Rethinking Ormond\u2019s disease: \u201cidiopathic\u201d retroperitoneal fibrosis in the era of IgG4-related disease. Medicine (Baltimore) 92(2):82\u201391. doi:\n                        10.1097\/MD.0b013e318289610f","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"428_CR17","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3109\/14397595.2014.931908","volume":"25","author":"BS Koo","year":"2015","unstructured":"Koo BS, Koh YW, Hong S, Kim YJ, Kim YG, Lee CK, Yoo B (2015) Clinicopathologic characteristics of IgG4-related retroperitoneal fibrosis among patients initially diagnosed as having idiopathic retroperitoneal fibrosis. Mod Rheumatol 25(2):194\u2013198. doi:\n                        10.3109\/14397595.2014.931908","journal-title":"Mod Rheumatol"},{"issue":"4","key":"428_CR18","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s10067-017-3542-8","volume":"36","author":"LG Pelkmans","year":"2017","unstructured":"Pelkmans LG, Hendriksz TR, Westenend PJ, Vermeer HJ, van Bommel EF (2017) Elevated serum IgG4 levels in diagnosis and treatment response in patients with idiopathic retroperitoneal fibrosis. Clin Rheumatol 36(4):903\u2013912. doi:\n                        10.1007\/s10067-017-3542-8","journal-title":"Clin Rheumatol"},{"issue":"3","key":"428_CR19","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/j.1365-2559.2007.02959.x","volume":"52","author":"K Yamashita","year":"2008","unstructured":"Yamashita K, Haga H, Mikami Y, Kanematsu A, Nakashima Y, Kotani H, Ogawa O, Manabe T (2008) Degree of IgG4+ plasma cell infiltration in retroperitoneal fibrosis with or without multifocal fibrosclerosis. Histopathology 52(3):404\u2013409. doi:\n                        10.1111\/j.1365-2559.2007.02959.x","journal-title":"Histopathology"},{"issue":"12","key":"428_CR20","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1097\/PAS.0b013e3181b72882","volume":"33","author":"Y Zen","year":"2009","unstructured":"Zen Y, Onodera M, Inoue D, Kitao A, Matsui O, Nohara T, Namiki M, Kasashima S, Kawashima A, Matsumoto Y, Katayanagi K, Murata T, Ishizawa S, Hosaka N, Kuriki K, Nakanuma Y (2009) Retroperitoneal fibrosis: a\u00a0clinicopathologic study with respect to immunoglobulin G4. Am J Surg Pathol 33(12):1833\u20131839","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"428_CR21","doi-asserted-by":"publisher","first-page":"256","DOI":"10.5114\/reum.2016.63667","volume":"54","author":"M Runowska","year":"2016","unstructured":"Runowska M, Majewski D, Puszczewicz M (2016) Retroperitoneal fibrosis \u2013 the state-of-the-art. Reumatologia 54(5):256\u2013263. doi:\n                        10.5114\/reum.2016.63667","journal-title":"Reumatologia"},{"issue":"3","key":"428_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s11739-016-1599-z","volume":"12","author":"GM Rossi","year":"2017","unstructured":"Rossi GM, Rocco R, Accorsi Buttini E, Marvisi C, Vaglio A (2017) Idiopathic retroperitoneal fibrosis and its overlap with IgG4-related disease. Intern Emerg Med 12(3):287\u2013299. doi:\n                        10.1007\/s11739-016-1599-z","journal-title":"Intern Emerg Med"},{"issue":"4","key":"428_CR23","first-page":"187","volume":"36","author":"C Alberti","year":"2015","unstructured":"Alberti C (2015) Drug-induced retroperitoneal fibrosis: short aetiopathogenetic note, from the past times of ergot-derivatives large use to currently applied bio-pharmacology. G\u00a0Chir 36(4):187\u2013191","journal-title":"G Chir"},{"issue":"6","key":"428_CR24","doi-asserted-by":"publisher","first-page":"e39788","DOI":"10.5812\/numonthly.39788","volume":"8","author":"MA Mohammadzadeh Rezaei","year":"2016","unstructured":"Mohammadzadeh Rezaei MA, Akhavan Rezayat A, Ardalan S (2016) Retroperitoneal fibrosis due to opium abuse: a case series and literature review. Nephrourol Mon 8(6):e39788. doi:\n                        10.5812\/numonthly.39788","journal-title":"Nephrourol Mon"},{"issue":"3","key":"428_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.7326\/M13-2648","volume":"161","author":"M Goldoni","year":"2014","unstructured":"Goldoni M, Bonini S, Urban ML, Palmisano A, De Palma G, Galletti E, Coggiola M, Buzio C, Mutti A, Vaglio A (2014) Asbestos and smoking as risk factors for idiopathic retroperitoneal fibrosis: a\u00a0case-control study. Ann Intern Med 161(3):181\u2013188. doi:\n                        10.7326\/M13-2648","journal-title":"Ann Intern Med"},{"issue":"9419","key":"428_CR26","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/S0140-6736(04)16100-X","volume":"363","author":"T Uibu","year":"2004","unstructured":"Uibu T, Oksa P, Auvinen A, Honkanen E, Metsarinne K, Saha H, Uitti J, Roto P (2004) Asbestos exposure as a\u00a0risk factor for retroperitoneal fibrosis. Lancet 363(9419):1422\u20131426. doi:\n                        10.1016\/S0140-6736(04)16100-X","journal-title":"Lancet"},{"issue":"3","key":"428_CR27","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/iju.12234","volume":"21","author":"S Mertens","year":"2014","unstructured":"Mertens S, Zeegers AG, Wertheimer PA, Hendriksz TR, van Bommel EF (2014) Efficacy and complications of urinary drainage procedures in idiopathic retroperitoneal fibrosis complicated by extrinsic ureteral obstruction. Int J Urol 21(3):283\u2013288. doi:\n                        10.1111\/iju.12234","journal-title":"Int J Urol"},{"issue":"1","key":"428_CR28","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1089\/end.2013.0332","volume":"28","author":"A Bourdoumis","year":"2014","unstructured":"Bourdoumis A, Kachrilas S, Kapoor S, Zaman F, Papadopoulos G, Buchholz N, Masood J (2014) The use of a\u00a0thermoexpandable metal alloy stent in the minimally invasive management of retroperitoneal fibrosis: a\u00a0single center experience from the United kingdom. J\u00a0Endourol 28(1):96\u201399. doi:\n                        10.1089\/end.2013.0332","journal-title":"J Endourol"},{"issue":"5\u20136","key":"428_CR29","doi-asserted-by":"publisher","first-page":"E417","DOI":"10.5489\/cuaj.1395","volume":"7","author":"N Haddad","year":"2013","unstructured":"Haddad N, Andonian S, Anidjar M (2013) Simultaneous bilateral subcutaneous pyelovesical bypass as a\u00a0salvage procedure in refractory retroperitoneal fibrosis. Can Urol Assoc\u00a0J 7(5\u20136):E417\u2013420. doi:\n                        10.5489\/cuaj.1395","journal-title":"Can Urol Assoc J"},{"issue":"6","key":"428_CR30","first-page":"871","volume":"33","author":"L Gao","year":"2015","unstructured":"Gao L, Wang H, Xu Y, Zhang Z (2015) Computed tomography parameters can be used as predictive markers for the improvement of renal function in patients with retroperitoneal fibrosis. Clin Exp Rheumatol 33(6):871\u2013876","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"428_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00120-014-3713-z","volume":"54","author":"S Kukuk","year":"2015","unstructured":"Kukuk S, Kretschmer A, Bruck H, Roth S, Brandt AS (2015) Retroperitoneale Fibrose: Entwicklung eines Biomarkerprofils zur Diagnostik und Verlaufskontrolle. Urologe\u00a0A 54(1):52\u201361. doi:\n                        10.1007\/s00120-014-3713-z","journal-title":"Urologe A"},{"issue":"1","key":"428_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5152\/dir.2013.13132","volume":"20","author":"L Kamper","year":"2014","unstructured":"Kamper L, Brandt AS, Ekamp H, Hofer M, Roth S, Haage P, Piroth W (2014) The potential role of modern US in the follow-up of patients with retroperitoneal fibrosis. Diagn Interv Radiol 20(1):3\u20138. doi:\n                        10.5152\/dir.2013.13132","journal-title":"Diagn Interv Radiol"},{"issue":"1","key":"428_CR33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4021\/jocmr1254e","volume":"5","author":"AS Brandt","year":"2013","unstructured":"Brandt AS, Kamper L, Kukuk S, Piroth W, Haage P, Roth S (2013) An aid to decision-making in therapy of retroperitoneal fibrosis: dynamic enhancement analysis of gadolinium MRI. J\u00a0Clin Med Res 5(1):49\u201356. doi:\n                        10.4021\/jocmr1254e","journal-title":"J Clin Med Res"},{"issue":"6","key":"428_CR34","doi-asserted-by":"publisher","first-page":"459","DOI":"10.5152\/dir.2014.14027","volume":"20","author":"L Kamper","year":"2014","unstructured":"Kamper L, Brandt AS, Ekamp H, Abanador-Kamper N, Piroth W, Roth S, Haage P (2014) Diffusion-weighted MRI findings of treated and untreated retroperitoneal fibrosis. Diagn Interv Radiol 20(6):459\u2013463. doi:\n                        10.5152\/dir.2014.14027","journal-title":"Diagn Interv Radiol"},{"issue":"1052","key":"428_CR35","doi-asserted-by":"crossref","first-page":"20150145","DOI":"10.1259\/bjr.20150145","volume":"88","author":"L Kamper","year":"2015","unstructured":"Kamper L, Haage P, Brandt AS, Piroth W, Abanador-Kamper N, Roth S, Ekamp H (2015) Diffusion-weighted MR imaging in the follow-up of chronic periaortitis. Br J Radiol 88(1052):20150145","journal-title":"Br J Radiol"},{"issue":"1056","key":"428_CR36","doi-asserted-by":"publisher","first-page":"20150526","DOI":"10.1259\/bjr.20150526","volume":"88","author":"G Bier","year":"2015","unstructured":"Bier G, Henes J, Eulenbruch C, Xenitidis T, Nikolaou K, Horger M (2015) Perfusion-based assessment of disease activity in untreated and treated patients with aortitis and chronic periaortitis: correlation with CT morphological, clinical and serological data. Br J Radiol 88(1056):20150526. doi:\n                        10.1259\/bjr.20150526","journal-title":"Br J Radiol"},{"issue":"4","key":"428_CR37","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.acra.2016.10.013","volume":"24","author":"G Bier","year":"2017","unstructured":"Bier G, Kurucay M, Henes J, Xenitidis T, Preibsch H, Nikolaou K, Horger M (2017) Monitoring disease activity in patients with aortitis and chronic periaortitis undergoing immunosuppressive therapy by perfusion CT. Acad Radiol 24(4):470\u2013477. doi:\n                        10.1016\/j.acra.2016.10.013","journal-title":"Acad Radiol"},{"key":"428_CR38","doi-asserted-by":"publisher","unstructured":"Treglia G, Mattoli MV, Bertagna F, Giubbini R, Giordano A (2013) Emerging role of Fluorine-18-fluorodeoxyglucose positron emission tomography in patients with retroperitoneal fibrosis: a\u00a0systematic review. Rheumatol Int. 33(3):549\u2013555. doi:\n                        10.1007\/s00296-012-2576-0","DOI":"10.1007\/s00296-012-2576-0"},{"issue":"9","key":"428_CR39","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1007\/s00259-016-3351-3","volume":"43","author":"V Ruhlmann","year":"2016","unstructured":"Ruhlmann V, Poeppel TD, Brandt AS, Gruneisen J, Ruhlmann M, Theysohn JM, Forsting M, Bockisch A, Umutlu L (2016) (18)F-FDG PET\/MRI evaluation of retroperitoneal fibrosis: a\u00a0simultaneous multiparametric approach for diagnosing active disease. Eur J Nucl Med Mol Imaging 43(9):1646\u20131652. doi:\n                        10.1007\/s00259-016-3351-3","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl 103 (1)","key":"428_CR40","first-page":"146","volume":"35","author":"K Thuermel","year":"2017","unstructured":"Thuermel K, Einspieler I, Wolfram S, Moog P, Meier R, Schwaiger M, Heemann U (2017) Disease activity and vascular involvement in retroperitoneal fibrosis: first experience with fully integrated 18F-fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging compared to clinical and laboratory parameters. Clin Exp Rheumatol 35(Suppl 103 (1)):146\u2013154","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"428_CR41","first-page":"776","volume":"30","author":"MG Catanoso","year":"2012","unstructured":"Catanoso MG, Spaggiari L, Magnani L, Pipitone N, Versari A, Boiardi L, Pazzola G, Pattacini P, Salvarani C (2012) Efficacy of infliximab in a\u00a0patient with refractory idiopathic retroperitoneal fibrosis. Clin Exp Rheumatol 30(5):776\u2013778","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"428_CR42","first-page":"332","volume":"10","author":"I Dedinska","year":"2016","unstructured":"Dedinska I, Svetlik D, Adamicova K, Machalekova K, Makovicky P, Jezikova A, Laca L, Miklusica J, Galajda P, Mokan M (2016) Treatment of Ormond disease and idiopathic membranous glomerulonephritis by using rituximab. Iran J Kidney Dis 10(5):332\u2013335","journal-title":"Iran J Kidney Dis"},{"issue":"Suppl 103 (1)","key":"428_CR43","first-page":"226","volume":"35","author":"FM Perrotta","year":"2017","unstructured":"Perrotta FM, Fici M, Guerra G, Brunese L, Salvarani C, Lubrano E (2017) Chronic periaortitis with retroperitoneal fibrosis successfully treated with first line tocilizumab monotherapy: a\u00a0case report. Clin Exp Rheumatol 35(Suppl 103 (1)):226\u2013227","journal-title":"Clin Exp Rheumatol"},{"issue":"3 Suppl 82","key":"428_CR44","first-page":"S79","volume":"32","author":"J Loricera","year":"2014","unstructured":"Loricera J, Blanco R, Castaneda S, Humbria A, Ortego-Centeno N, Narvaez J, Mata C, Melchor S, Aurrecoechea E, Calvo-Alen J, Lluch P, Moll C, Minguez M, Herrero-Beaumont G, Bravo B, Rubio E, Freire M, Peiro E, Gonzalez-Vela C, Rueda-Gotor J, Pina T, Palmou-Fontana N, Calvo-Rio V, Ortiz-Sanjuan F, Gonzalez-Gay MA (2014) Tocilizumab in refractory aortitis: study on 16 patients and literature review. Clin Exp Rheumatol 32(3 Suppl 82):S79\u201389","journal-title":"Clin Exp Rheumatol"},{"key":"428_CR45","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2147\/RRU.S115448","volume":"8","author":"AS Laroche","year":"2016","unstructured":"Laroche AS, Bell RZ, Bezzaoucha S, Foldes E, Lamarche C, Vallee M (2016) Retroperitoneal fibrosis: retrospective descriptive study on clinical features and management. Res Rep Urol 8:175\u2013179. doi:\n                        10.2147\/RRU.S115448","journal-title":"Res Rep Urol"},{"issue":"1","key":"428_CR46","doi-asserted-by":"publisher","first-page":"34","DOI":"10.14712\/23362936.2016.3","volume":"117","author":"M Prucha","year":"2016","unstructured":"Prucha M, Kolombo I, Stadler P (2016) Combination of steroids and azathioprine in the treatment of Ormond\u2019s disease \u2013 a single centre retrospective analysis. Prague Med Rep 117(1):34\u201341. doi:\n                        10.14712\/23362936.2016.3","journal-title":"Prague Med Rep"},{"issue":"2","key":"428_CR47","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/ckj\/sfv148","volume":"9","author":"FE Bilt van der","year":"2016","unstructured":"van der Bilt FE, Hendriksz TR, van der Meijden WAG, Brilman LG, van Bommel E (2016) Outcome in patients with idiopathic retroperitoneal fibrosis treated with corticosteroid or tamoxifen monotherapy. Clin Kidney\u00a0J 9(2):184\u2013191","journal-title":"Clin Kidney J"},{"issue":"10","key":"428_CR48","doi-asserted-by":"crossref","first-page":"928","DOI":"10.2298\/VSP140426076H","volume":"72","author":"J Hadzi-Djokic","year":"2015","unstructured":"Hadzi-Djokic J, Pejcic T, Basic D, Vukomanovic I, Dzamic Z, Acimovic M, Radovanovic M (2015) Idionathic retroneritoneal fibrosis: a report on 15 patients. Vojnosanit Pregl 72(10):928\u2013931","journal-title":"Vojnosanit Pregl"},{"issue":"2","key":"428_CR49","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10067-015-3022-y","volume":"35","author":"R Yachoui","year":"2016","unstructured":"Yachoui R, Sehgal R, Carmichael B (2016) Idiopathic retroperitoneal fibrosis: clinicopathologic features and outcome analysis. Clin Rheumatol 35(2):401\u2013407. doi:\n                        10.1007\/s10067-015-3022-y","journal-title":"Clin Rheumatol"},{"issue":"4","key":"428_CR50","doi-asserted-by":"publisher","first-page":"816","DOI":"10.4103\/1319-2442.160226","volume":"26","author":"J Labidi","year":"2015","unstructured":"Labidi J, Ariba YB, Chargui S, Bousetta N, Louzir B, Othmani S (2015) Retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment and outcomes. Saudi J Kidney Dis Transpl 26(4):816\u2013822. doi:\n                        10.4103\/1319-2442.160226","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"6","key":"428_CR51","doi-asserted-by":"publisher","first-page":"804","DOI":"10.4103\/0366-6999.152648","volume":"128","author":"HJ Zhou","year":"2015","unstructured":"Zhou HJ, Yan Y, Zhou B, Lan TF, Wang XY, Li CS (2015) Retroperitoneal fibrosis: a\u00a0retrospective clinical data analysis of 30 patients in a\u00a010-year period. Chin Med J (Engl) 128(6):804\u2013810. doi:\n                        10.4103\/0366-6999.152648","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"428_CR52","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s00120-014-3712-0","volume":"54","author":"AS Brandt","year":"2015","unstructured":"Brandt AS, Kukuk S, Dreger NM, Muller E, Roth S (2015) Therapie der retroperitonealen Fibrose: Funktionelle Behandlungsergebnisse. Urologe\u00a0A 54(1):62\u201369. doi:\n                        10.1007\/s00120-014-3712-0","journal-title":"Urologe A"},{"issue":"4","key":"428_CR53","doi-asserted-by":"publisher","first-page":"R156","DOI":"10.1186\/ar4671","volume":"16","author":"I Mizushima","year":"2014","unstructured":"Mizushima I, Inoue D, Yamamoto M, Yamada K, Saeki T, Ubara Y, Matsui S, Masaki Y, Wada T, Kasashima S, Harada K, Takahashi H, Notohara K, Nakanuma Y, Umehara H, Yamagishi M, Kawano M (2014) Clinical course after corticosteroid therapy in IgG4-related aortitis\/periaortitis and periarteritis: a\u00a0retrospective multicenter study. Arthritis Res Ther 16(4):R156. doi:\n                        10.1186\/ar4671","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"428_CR54","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1007\/s00296-014-3002-6","volume":"34","author":"H Liu","year":"2014","unstructured":"Liu H, Zhang G, Niu Y, Jiang N, Xiao W (2014) Retroperitoneal fibrosis: a\u00a0clinical and outcome analysis of 58 cases and review of literature. Rheumatol Int 34(12):1665\u20131670. doi:\n                        10.1007\/s00296-014-3002-6","journal-title":"Rheumatol Int"},{"issue":"6","key":"428_CR55","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s10067-013-2225-3","volume":"32","author":"A Fernandez-Codina","year":"2013","unstructured":"Fernandez-Codina A, Martinez-Valle F, Castro-Marrero J, Detorres I, Vilardell-Tarres M, Ordi-Ros J (2013) Idiopathic retroperitoneal fibrosis: a\u00a0clinicopathological study in 24 Spanish cases. Clin Rheumatol 32(6):889\u2013893. doi:\n                        10.1007\/s10067-013-2225-3","journal-title":"Clin Rheumatol"},{"issue":"5","key":"428_CR56","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ejim.2012.11.010","volume":"24","author":"EF Bommel van","year":"2013","unstructured":"van Bommel EF, Pelkmans LG, van Damme H, Hendriksz TR (2013) Long-term safety and efficacy of a\u00a0tamoxifen-based treatment strategy for idiopathic retroperitoneal fibrosis. Eur J Intern Med 24(5):444\u2013450. doi:\n                        10.1016\/j.ejim.2012.11.010","journal-title":"Eur J Intern Med"},{"key":"428_CR57","doi-asserted-by":"publisher","DOI":"10.1159\/000357814","author":"AS Brandt","year":"2014","unstructured":"Brandt AS, Kamper L, Kukuk S, Haage P, Roth S (2014) Tamoxifen monotherapy in the treatment of retroperitoneal fibrosis. Urol Int. doi:\n                        10.1159\/000357814","journal-title":"Urol Int"},{"issue":"9788","key":"428_CR58","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S0140-6736(11)60934-3","volume":"378","author":"A Vaglio","year":"2011","unstructured":"Vaglio A, Palmisano A, Alberici F, Maggiore U, Ferretti S, Cobelli R, Ferrozzi F, Corradi D, Salvarani C, Buzio C (2011) Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial. Lancet 378(9788):338\u2013346. doi:\n                        10.1016\/S0140-6736(11)60934-3","journal-title":"Lancet"},{"issue":"3","key":"428_CR59","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1089\/lap.2013.0242","volume":"24","author":"NK Arvind","year":"2014","unstructured":"Arvind NK, Singh O, Ali Q, Singh J, Gupta SS, Sahay S (2014) Laparoscopic ureterolysis and omental wrapping in patients with retroperitoneal fibrosis and obstructive uropathy: a\u00a0single-center experience. J\u00a0Laparoendosc Adv Surg Tech\u00a0A 24(3):159\u2013164. doi:\n                        10.1089\/lap.2013.0242","journal-title":"J Laparoendosc Adv Surg Tech A"},{"issue":"5","key":"428_CR60","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.juro.2013.11.027","volume":"191","author":"R Ordorica","year":"2014","unstructured":"Ordorica R, Wiegand LR, Webster JC, Lockhart JL (2014) Ureteral replacement and onlay repair with reconfigured intestinal segments. J\u00a0Urol 191(5):1301\u20131306. doi:\n                        10.1016\/j.juro.2013.11.027","journal-title":"J Urol"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-017-0428-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-017-0428-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-017-0428-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,6]],"date-time":"2017-07-06T14:06:42Z","timestamp":1499350002000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-017-0428-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,22]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["428"],"URL":"https:\/\/doi.org\/10.1007\/s00120-017-0428-y","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,22]]}}}